Cisplatin, a non organic compound of platinum with wide antitumour activity is associated with renal toxicity, ototoxicity and myelosuppression within the therapeutic dosage range. The case we describe received in error cisplatin three times the planned therapeutic dose.
Case report
A 59-year-oldfemale patient was transferred to the intensive care unit from a hospital ward due to cisplatin overdosage.
In April 1986 an advanced ovarian carcinoma was found during explorative laparotomy with spread to peritoneum, liver and uterus. During the following five months the patient received cisplatin 150 mg each month and in November 1986 was admitted for a total hysterectomy.
In January 1987 the patient was readmitted to the Hospital and received in error 150 mg of cisplatin per day for three consecutive days instead of 50 mg per day (a total dose 450 mg within three days). On day 4 following the cisplatin overdosage the patient developed numbness of the upper and lower limbs, headache and hyperpnoea. On day 6 she became confused and was transferred to the intensive care unit.
At the time of admission her blood gases were as follows: Pa0 2 13.3 kPa, PaC0 2 2.79 kPa, pH 7.654 and base excess 3.6 mmol/l. Electrocardiogram, central venous pressure, direct arterial blood pressure and urine output were monitored continuously. One hour later the patient became unconscious, a new arterial sample was obtained. PaC0 2 was now 1.86 kPa, pH 7.720 and base excess -0.3 mmol/l. The patient was intubated and ventilated mechanically with the appropriate tidal volume and respiratory rate to restore the PaC0 2 to normal or near normal levels.
By this time the K+ and P renal losses were significant and K+ daily replacement reached the 18 g per day. Such high doses of K+ were necessary to restore the ECG disturbances due to hypokalaemia. During the period in the Journal of the Royal Society of Medicine Volume 82 November 1989 ijMĩ ntensive care unit the patient's creatinine clearance varied between 42 and 56 ml/min. Blood urea and creatinine levels were moderately elevated. Occurrence and course of myelosuppression is shown in Table 1 . The patient was transfused with a total of 26 units of platelets and 9 units of blood.
On day 8 the patient was extubated and on day 10 was transferred to the ward. In August 1988 she was clinically examined for the last time and so far no recurrence of the tumour has been detected. The patient is in excellent general condition except for a hearing impairment.
Discussion
Impairment of renal function is the major dose limiting toxicity of cisplatin'. With a dose three times higher than the recommended, nephrotoxicity was expected to occur and indeed occurred. The severe K+ losses due to renal failure may be life threatening unless ECG and K+ levels are carefully monitored and K+ is replaced. Acute vascular ischaemic events after cisplatin based combination chemotherapy have been reported" but we did not observe such ischaemic events.
Scintigraphy and examinations of specimens removed at postmortem have shown that penetration of the drug into the central nervous system is poor". However, a PaC0 2 as low as 1.86 kPa developed within one hour due to vigorous hyperventilation suggesting that the drug dose of 450 mg crossed the blood-brain barrier and had a direct effect on the respiratory centre. The consequence of severe hypocapnia and the accompanied acid base disturbances constituted the major problem of the overdose intoxication with cisplatin. Mechanical ventilation is mandatory for a few days until the central nervous system recovers from the drug. Renal toxicity and bone marrow suppression though of major concern will not become life threatening within hours although severe hypocapnia and acute acid-base disturbances will. 
